Cognitive impairments associated with breast cancer treatments: results from a longitudinal study-Reference-Cited by-同舟云学术

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

Published:2008-07-16 Issue:1 Volume:116 Page:113-123
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Quesnel Catherine,Savard Josée,Ivers Hans

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0114-2.pdf

Reference38 articles.

1. Berglund G, Bolund C, Fornander T et al (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 27:1075–1081

2. Ahles TA, Saykin AJ, Furtenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493. doi: 10.1200/JCO.20.2.485

3. Brezden CB, Phillips KA, Abdolell M et al (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701

4. Schagen SB, van Dam FS, Muller MJ et al (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Am Cancer Soc 85:640–650

5. Tchen N, Juffs HG, Downie FP et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183. doi: 10.1200/JCO.2003.01.119

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-κB/NLRP3 signaling in a breast cancer mouse model;Neuropharmacology;2024-08

2. A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?;Annals of Physical and Rehabilitation Medicine;2024-06

3. Chemotherapy‐induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021;Cancer Reports;2024-02

4. Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice;Science Translational Medicine;2023-09-27

5. Comparing the Mechanism of Change of Cognitive-Behavioral Therapy and Emotion Efficacy Therapy in Improving Psychological Adjustment of Women with Breast Cancer: the Role of Cognitive and Emotional Flexibility, Illness Perception, and Valued Action;International Journal of Cognitive Therapy;2023-08-12